Breast and ovarian cancer linked to thousands of gene variants
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
On Sept. 3, 2024, a major study led by the UC Davis Comprehensive Cancer Center (UC DAVIS) has…
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
On May 15, 2024, the American Association for Cancer Research (AACR) released its biennial Cancer Disparities Progress Report…
Asian American and Pacific Islander History Month celebrates the scientific accomplishments of several firsts, from the first chemo…
On Apr. 30, 2024, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…
On Dec. 18, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced a study that showed…
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenメs Health Research, an effort led…
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
On Aug. 31, 2023, the U.S. Food and Drug Administration (FDA) cleared for marketing the updated 23andMe Personal…
On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…
On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…
On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…
On Feb. 8, 2022, a research team led at Boston University School of Public Health reported on links…
On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…
On Jan. 28, 2021, National Institutes of Health (NIH) researchers reported that pregnant women who experienced severe symptoms…
On Jan. 25, 2021, the National Institutes of Health (NIH) announced that in large clinical trial conducted worldwide,…
On Jan. 12, 2021, the Tufts Center for the Study of Drug Development reported that ever more complex…
On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…